The HCC surveillance guidelines included recommendations for routine HCC surveillance via 6-monthly ultrasound (US) imaging for people with compensated liver cirrhosis, with the potential addition of alpha-fetoprotein (AFP) blood testing. The gene discussed is AFP; the disease is cirrhosis of liver.